I think the reason for the collapse is simple. Take a look at the run-up in the 3 months prior to the earnings. Those were people buying because the price was going up, not because they heard of the progress in HILL's business. It only took a small correction to start the flush of all these silly retail traders. My issue with these types of 'investors' is that, before the market relives them of their investment dollars, they create massive volatility. Once all the margin calls are executed we'll go back to normal until the next crop of imbeciles save up enough to lose it all over again. Irritating situation but they're all part of the human gene pool and there's no escape from them.
I'm not advising anyone to sell the stock. I'm suggesting that if, like 90% of the folks here, you know nothing about Dot Hill, and you don't own the stock based on your due diligence of HILL's technology and financials, you'd be better off exiting here. It's going to take a few slow quarters of incremental growth before the market starts to understand the story here. In that time players with no understanding of what they own will be shaken out for certain. If you own the stock based on the technology and the financials then what's another few quarters? Today's pps, or tomorrow's lower pps, is irrelevant in the scheme of things. Assuming you can time the market for starting and ending positions is simple gambling and there the table never loses so you cannot win.
Small retail investors. like you and me, can only win by knowing what they're buying. The guys here who don't know HILL are certain to lose so why prolong the misery?
It's a tad troublesome when you see such intense promotion for a stock. I'm forced to stand back and examine the situation in more detail. Why is it necessary to pump the issue with such ferocity?
Why would AstraZeneca have purchased Omthera if they considered it likely that Epanova could be successfully challenged by Amarin?
I'm no scientist or legal whiz but I suspect the experts at AstraZeneca are more astute than the experts here or those at Amarin.
Well buddy, if you think I'm going to take the number of shares in hill I've got and your target price and risk breaking my calculator by multiplying them you've got another thing comin'
Interesting that Formula (presumably with the agreement of Asseco) decided not to buy 3 million shares. That would have maintained the status quo. By opting for just 700k, Formula has made it possible for an external bid for MGIC to succeed. I'm pretty sure if someone offered $17.50 or more they would likely now get more than the needed 92.5% of the votes of the non-Formula shareholders who will hold 54.1% after the offering is taken up. Up to this point, a bid without the support of Formula could not succeed. Now a hostile bid without the support of Formula can succeed. Can anyone speculate as to the possible reason Formula/Asseco have decided to relinquish control over MGIC? I can't think of a good reason. Why would Asseco/Formula purposefully make it possible for them to lose MGIC?
No, technically, unless they throw the money away, the share price should not go down at all. Remember, after the secondary, apart from all those extra shares, there's a counter-balancing additional cash pile. There's an unfortunate history of companies raising funds through secondaries that should have been raised intrinsically through the business. Oftentimes the market therefore classifies secondaries as management failures, particularly secondaries used to finance working capital. Working capital should come from the business, not the pockets of shareholders. The only valid excuse here is acquisitions. That's why the market is reacting poorly. The reason for the secondary may indeed be to finance acquisitions but unfortunately the dope who wrote the PR failed to make that clear.
Because AVID is unable yet to file amended and corrected financial statements with the SEC for the years, 2009, 2010, 2011, and I guess regular financial statements for 2012 and 2013.
What I'd like to know is how their accounting function and their prior auditors (E&Y) could do such a bad job. Revenue recognition can be tricky for companies like AVID but it's not rocket science. There must a few skelitons in the closets methinks!
yes I know. After five losing tails, one would have thought the coin might have turned up heads but it was not to be. Amarin remains an acursed entity it would appear!
NCE relates to the chemical originality of the drug (New Chemical Element). It has nothing to do with the target population. NCE designation bestows 5 years exclusivity. Amarin just got 3 years and half of that has already expired. Such is the 'efficiency' of the FDA.
Ooops, forgot the statement:-
"Amarin is reviewing the FDA's reasoning for granting Vascepa three-year, rather than five-year, exclusivity, and evaluating whether to challenge the decision," stated John Thero, President and Chief Executive Officer of Amarin. "Over the past year, Amarin has significantly bolstered its patent position for Vascepa thereby decreasing the relative value of FDA marketing exclusivity in protecting Vascepa. Amarin now has 40 issued and allowed U.S. patents that provide the primary means to protect the exclusivity of Vascepa to 2030. These patents, all but two of which expire in 2030, are anticipated to protect the exclusivity of Vascepa well beyond the FDA marketing exclusivity period and to augment the protection afforded by Amarin's trade secrets and existing manufacturing barriers to entry."
It's time to dump IKAN. Why screw around trying to improve copper-based bandwidth if wireless fiber (DIDO) works? Before responding, please google Steve Perlman pCell. It sounds too good to be true except Perlman has a well-documented history for inventing the impossible.
If just 2 engineers can leave Yahoo and create $19B value in just a couple of years, one is left scratching one's head as to the reason that the thousands of engineers who remained cannot create any value at Yahoo. Surely the key failure at Yahoo must therefore be management!
Why no Incredimail app for Android?
Android id the dominant OS in the smart phone/devices segment, It seems almost unbelievable that a company claiming to be serious about this space would not have a toe in the water.